Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative

被引:5
|
作者
Yuan, Yuan [1 ]
Pan, Kathy [2 ]
Mortimer, Joanne [1 ]
Chlebowski, Rowan T. [2 ]
Luo, Juhua [3 ]
Yan, Jessica E. [2 ]
Yost, Susan E. [1 ]
Kroenke, Candyce H. [4 ]
Adams-Campbell, Lucile [5 ]
Nassir, Rami [6 ]
Sun, Yangbo [7 ]
Shadyab, Aladdin H. [8 ]
Vitolins, Mara Z. [9 ]
Saquib, Nazmus [10 ]
Wild, Robert A. [11 ]
Manson, JoAnn E. [12 ]
Nelson, Rebecca A. [1 ]
机构
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd,Bldg 51, Duarte, CA 91010 USA
[2] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA 90509 USA
[3] Univ Indiana, Bloomington, IN USA
[4] Kaiser Permanente, Oakland, CA USA
[5] Georgetown Univ, Sch Med, Washington, DC USA
[6] Al Umm Qura Univ, Sch Med, Dept Pathol, Mecca, Saudi Arabia
[7] Univ Iowa, Iowa City, IA USA
[8] Univ Calif San Diego, La Jolla, CA 92093 USA
[9] Wake Forest Sch Med, Winston Salem, NC 27101 USA
[10] Sulaiman Al Rajhi Coll Med, Al Bukairiyah, Saudi Arabia
[11] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[12] Harvard Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
metabolic syndrome; postmenopausal women; risk factors; triple-negative breast cancer; Women's Health Initiative;
D O I
10.1002/cncr.33407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Triple-negative breast cancer (TNBC) has a high recurrence risk and poor clinical outcomes. Associations between metabolic syndrome (MetS) risk components and mortality in postmenopausal women with TNBC were examined in the Women's Health Initiative. METHODS: Five hundred forty-four postmenopausal women were diagnosed with nonmetastatic TNBC. Baseline risk components included a high waist circumference (>= 88 cm), high blood pressure, hypercholesterolemia, and diabetes. Groups were categorized by the number of MetS risk components: none, 1 or 2, or 3 or 4. Hazard ratios (HRs) and 95% confidence intervals (CIs) across groups were computed with multivariable adjusted Cox models. Outcomes included breast cancer-specific mortality and breast cancer overall mortality (breast cancer followed by death from any cause). Variables in the multivariable model included age at TNBC diagnosis; race/ ethnicity; income; education; clinical/observational trial status; history of oral contraceptive, hormone, and/or statin use; cancer stage; and chemotherapy and/or radiation treatment status. RESULTS: Of the 544 participants with TNBC, 33% had no MetS risk components (n = 178), 59% had 1 or 2 risk components (n = 323), and 8% had 3 or 4 risk components (n = 43). After a median follow-up from diagnosis of 8.3 years, multivariable results showed that women with 3 or 4 risk components had a nonsignificantly higher risk of breast cancer mortality (HR, 2.05; 95% CI, 0.94-4.47 trend P =.114) and a significantly higher risk of overall mortality (HR, 2.13; 95% CI, 1.22-3.71; trend P =.006) versus women with 0 risk components. CONCLUSIONS: Postmenopausal women with TNBC and 3 or 4 MetS risk components have a nonsignificantly higher breast cancer mortality risk and a significantly higher overall mortality risk, likely because of negative influences of metabolic risk factors on several causes of death.
引用
收藏
页码:1658 / 1667
页数:10
相关论文
共 50 条
  • [1] Metabolic syndrome impacts survival in postmenopausal women with triple negative breast cancer: Results from the women's health initiative
    Yuan, Yuan
    Nelson, Rebecca
    Pan, Kathy
    Yan, Jessica
    Yost, Susan E.
    Nassir, Rami
    Chlebowski, Rowan
    CANCER RESEARCH, 2020, 80 (04)
  • [2] African Ancestry and Triple-Negative Breast Cancer in the Women's Health Initiative
    Jones, Veronica C.
    Chlebowski, Rowan T.
    Pan, Kathy
    Kruper, Laura
    Mortimer, Joanne
    Nassir, Ramir
    Nelson, Rebecca A.
    AMERICAN SURGEON, 2022, 88 (07) : 1722 - 1724
  • [3] Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative
    Chlebowski, Rowan T.
    Aragaki, Aaron K.
    Pan, Kathy
    Simon, Michael S.
    Neuhouser, Marian L.
    Haque, Reina
    Rohan, Thomas E.
    Wactawski-Wende, Jean
    Orchard, Tonya S.
    Mortimer, Joanne E.
    Lane, Dorothy
    Kaunitz, Andrew M.
    Desai, Pinkal
    Wild, Robert A.
    Barac, Ana
    Manson, JoAnn E.
    CANCER, 2024, 130 (18) : 3147 - 3156
  • [4] Features of the metabolic syndrome and survival after a diagnosis of breast cancer in the Women's Health Initiative (WHI).
    Beebe-Dimmer, Jennifer Lynn
    Hastert, Theresa
    Silbiger, Daniel
    Ruterbusch, Julie
    Cespedes, Elizabeth
    Chlebowski, Rowan T.
    Freudenheim, Jo L.
    Manson, JoAnn E.
    Neuhouser, Marian
    Ho, Gloria
    Stefanick, Marcia L.
    Strickler, Howard D.
    Caan, Bette Jane
    Simon, Michael S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative
    Park, Na-Jin
    Chang, Yuefang
    Bender, Catherine
    Conley, Yvette
    Chlebowski, Rowan T.
    van Londen, G. J.
    Foraker, Randi
    Wassertheil-Smoller, Sylvia
    Stefanick, Marcia L.
    Kuller, Lewis H.
    PLOS ONE, 2017, 12 (09):
  • [6] Infertility and risk of postmenopausal breast cancer in the women's health initiative
    Farland, Leslie V.
    Lind, Kimberly E.
    Thomson, Cynthia A.
    Saquib, Nazmus
    Shadyab, Aladdin H.
    Schnatz, Peter F.
    Robles-Morales, Rogelio
    Qi, Lihong
    Strickler, Howard
    Lane, Dorothy S.
    Murugappan, Gayathree
    Roe, Denise J.
    Harris, Holly R.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (03) : 497 - 506
  • [7] Infertility and risk of postmenopausal breast cancer in the women’s health initiative
    Leslie V. Farland
    Kimberly E. Lind
    Cynthia A. Thomson
    Nazmus Saquib
    Aladdin H. Shadyab
    Peter F. Schnatz
    Rogelio Robles-Morales
    Lihong Qi
    Howard Strickler
    Dorothy S. Lane
    Gayathree Murugappan
    Denise J. Roe
    Holly R. Harris
    Breast Cancer Research and Treatment, 2024, 205 : 497 - 506
  • [8] Estimating mortality in women with triple-negative breast cancer: The 'ESTIMATE triple-negative' tool
    Leone, Jose P.
    Graham, Noah
    Leone, Julieta
    Tolaney, Sara M.
    Leone, Bernardo A.
    Freedman, Rachel A.
    Hassett, Michael J.
    Vallejo, Carlos T.
    Winer, Eric P.
    Lin, Nancy U.
    Tayob, Nabihah
    EUROPEAN JOURNAL OF CANCER, 2023, 189
  • [9] Higher Mortality Risk in African American Women with Triple-Negative Breast Cancer
    Nierengarten, Mary Beth
    CANCER, 2021, 127 (20) : 3712 - 3713
  • [10] Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative
    Pan, Kathy
    Chlebowski, Rowan T.
    Mortimer, Joanne E.
    Gunther, Marc J.
    Rohan, Thomas
    Vitolins, Mara Z.
    Adams-Campbell, Lucile L.
    Ho, Gloria Y. F.
    Cheng, Ting-Yuan David
    Nelson, Rebecca A.
    CANCER, 2020, 126 (16) : 3638 - 3647